We expect somewhere in the range of $760m in revenue.
From one product in essentially one jurisdiction.
If we only take that one product, nothing else, just one and safely assume it will be approved in many other parts of the world , our revenues from just Illuccix will easily double over the next 18-24 months. That's a very conservative estimate in my opinion. The FDA is the benchmark authority. Approvals in other jurisdictions are not a question of if but rather when.
The maths is pretty simple and very compelling.
Short Term trading, analysis and TLX noise - No investors keep out, page-605
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.85 |
Change
-1.460(7.19%) |
Mkt cap ! $6.307B | |||
| Open | High | Low | Value | Volume |
| $18.92 | $19.57 | $18.68 | $107.9M | 5.682M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14410 | $18.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.99 | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |